SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2021-02-22
👔
AbbVie Inc.
@ABBV_InsiderForm 4 Filing: Hudson Thomas J Acquires shares of $ABBV
INSIDER TRANSACTION
0 corporate issuer
AbbVie Inc.
Ticker: $ABBV
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2021-02-18
Shares: 4,216
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Hudson Thomas J, holds the title of SVP, R&D and CSO at AbbVie Inc..
On 2021-02-18, the insider transacted 4,216 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Hudson Thomas J (SVP, R&D and CSO) acquisition 4216 shares ABBV
Post-Transaction Position: 23,859 shares
SEC Accession No: 0001179110-21-002045 (CIK: 1781947)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.